Short Interest In Cadence Pharmaceuticals Falls 10.2%
The most recent short interest data has been released by the NASDAQ for the 07/31/2013 settlement date, which shows a 356,691 share decrease in total short interest for Cadence Pharmaceuticals Inc , to 3,142,828, a decrease of 10.19% since 07/15/2013. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
According to the ETF Finder at ETF Channel, CADX makes up 2.28% of the Dynamic Biotechnology & Genome Portfolio ETF (PBE) which is lower by about 0.2% on the day Monday. In afternoon trading Monday, CADX was down about 2.3% on the day.